Current Report Filing (8-k)
01 August 2019 - 6:43AM
Edgar (US Regulatory)
0000816956
false
0000816956
2019-07-30
2019-07-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________
FORM
8-K
_________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July 31, 2019
_______________________________
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
_______________________________
New York
|
0-16093
|
16-0977505
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
525 French Road
Utica
,
New York
13502
(Address of Principal
Executive Offices) (Zip Code)
315
-
797-8375
(Registrant’s
telephone number, including area code)
N/A
(Former name or former address,
if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
CNMD
|
NASDAQ
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On July 31, 2019, CONMED Corporation issued
a press release announcing financial results for the second quarter ended June 30, 2019. A copy of this press release is attached
hereto as Exhibit 99.1.
The information in this Current Report on Form
8-K that is furnished under “Item 2.02. Results of Operations and Financial Condition” and Exhibit 99.1 attached hereto
shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated
by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such
filing.
|
Item 9.01
|
Financial Statements and Exhibits.
|
The following exhibit is included herewith:
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 31, 2019
|
CONMED CORPORATION
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ Todd W. Garner
|
|
Name:
|
Todd W. Garner
|
|
Title:
|
Executive Vice President-
|
|
|
Chief Financial Officer
|
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024